Souhaitez-vous accéder aux communiqués récents ?

- Company Confirms Previous 2018 Guidance for Neurology Franchise Net Sales and Non-GAAP Adjusted EBITDA - - Amends Existing Agreement for CAMBIA Line Extension – - Announces New Co-Promotion...

LAKE FOREST, Ill., May 07, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate at the 2018 UBS Global Healthcare Conference in a...

LAKE FOREST, Ill., May 03, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release first-quarter 2018 financial results on Thursday, May 10, 2018, before the open...

NEWARK, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced the appointment of John B. Thomas as Senior Vice President, Investor Relations and Corporate...

NEWARK, Calif., April 09, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) made a grant on April 2, 2018 of 91,324 restricted stock units (“RSUs”) and 91,324 target performance stock units...

NEWARK, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced the appointment of Stan Bukofzer, M.D., as Senior Vice President, Chief Medical and Scientific Officer,...

NEWARK, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced it has signed a lease for its new corporate headquarters at 100 South Saunders Road in Lake Forest,...

NEWARK, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate in fireside chats at the following healthcare...

- Annual Net Revenues of $381 Million - - Collegium, Slán Transactions and Expanded Neurology Field Force Position Company for Improved Profitability in 2018 and Beyond – - New Corporate...

NEWARK, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release fourth quarter fiscal year 2017 financial results on Tuesday, February 27, 2018,...